JNJ Johnson & Johnson PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: JNJ
- PE Ratio
As of May 9, 2025, the Johnson & Johnson stock's PE ratio is 17.02. This takes into account the latest EPS of $9.06 and stock price of $154.22. The PE ratio marks a decrease of 14% from its last 4 quarters average of 19.8.
JNJ PE ratio history
The PE ratio of Johnson & Johnson has averaged 45.09 over the last ten years. The current P/E ratio of 17.02 is 62% lower than the historical average. Looking back at the last ten years, JNJ's PE ratio peaked in the Dec 2017 quarter at 291.08, when the price was $139.72 and the EPS was $0.48. The lowest point was in the Jun 2024 quarter, when it reached 9.6 with a price of $146.16 and an EPS of $15.23.
Johnson & Johnson PE ratio by year
Maximum annual increase: 1,426.38% in 2017
Maximum annual decrease: -92.33% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 24.84 | 120.02% | $145.05 | $5.84 |
| 2023 | 11.29 | -56.34% | $156.74 | $13.88 |
| 2023 | 25.86 | 19.89% | $176.65 | $6.83 |
| 2022 | 21.57 | -23.37% | $171.07 | $7.93 |
| 2021 | 28.15 | 10.48% | $157.38 | $5.59 |
| 2019 | 25.48 | 14.11% | $145.75 | $5.72 |
| 2018 | 22.33 | -92.33% | $127.27 | $5.7 |
| 2017 | 291.08 | 1,426.38% | $139.72 | $0.48 |
| 2017 | 19.07 | 3.25% | $115.21 | $6.04 |
| 2016 | 18.47 | 1.99% | $102.72 | $5.56 |
| 2014 | 18.11 | -3.52% | $105.06 | $5.8 |
| 2013 | 18.77 | 6.47% | $92.35 | $4.92 |
| 2012 | 17.63 | -4.86% | $69.48 | $3.94 |
| 2012 | 18.53 | 45.33% | $65.58 | $3.54 |
| 2011 | 12.75 | -11.89% | $61.85 | $4.85 |
Johnson & Johnson PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 18.07 | -27.25% | $163.71 | $9.06 |
| Dec 2024 | 24.84 | -7.21% | $145.05 | $5.84 |
| Sep 2024 | 26.77 | 178.85% | $161.4 | $6.03 |
| Jun 2024 | 9.6 | -7.43% | $146.16 | $15.23 |
| Mar 2024 | 10.37 | -8.15% | $158.19 | $15.26 |
| Dec 2023 | 11.29 | -1.31% | $156.74 | $13.88 |
| Oct 2023 | 11.44 | -65.51% | $155.75 | $13.61 |
| Jul 2023 | 33.17 | 3.59% | $165.52 | $4.99 |
| Apr 2023 | 32.02 | 23.82% | $155 | $4.84 |
| Jan 2023 | 25.86 | 15.55% | $176.65 | $6.83 |
| Oct 2022 | 22.38 | -12.85% | $163.36 | $7.3 |
| Jul 2022 | 25.68 | 8.68% | $179.52 | $6.99 |
| Apr 2022 | 23.63 | 9.55% | $178.19 | $7.54 |
| Jan 2022 | 21.57 | -8.87% | $171.07 | $7.93 |
| Oct 2021 | 23.67 | -5.58% | $160.47 | $6.78 |
JNJ average PE ratio chart
JNJ's current PE ratio is lower than its 3, 5 and 10-year averages.
JNJ PE vs peers
In comparison to its peers LLY and ABT, JNJ's PE ratio is lower, but it is higher than NVS's and MRK's. Johnson & Johnson's PE ratio is trading below the peer average of 27.13.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.67 | $201.96B |
| PFE Pfizer Inc | 16.61 | $131.28B |
| NVS Novartis AG | 16.92 | $213.47B |
| JNJ Johnson & Johnson | 17.01 | $370.87B |
| ABT Abbott Laboratories | 17.1 | $229.64B |
| GILD Gilead Sciences Inc | 21.77 | $129.14B |
| MDT Medtronic plc | 25.92 | $110.06B |
| SYK Stryker Corp | 51.74 | $148.31B |
| LLY ELI LILLY & Co | 61.23 | $716.08B |
Frequently asked questions
What is Johnson & Johnson's PE ratio?
JNJ stock has a price to earnings ratio of 17.02 as of May 9, 2025.
What is the 3-year average PE ratio for Johnson & Johnson (JNJ)?
The average PE ratio for JNJ stock over the past 3 years is 20.96.
What is the 5-year average PE ratio for Johnson & Johnson (JNJ)?
The average PE ratio for JNJ stock over the past 5 years is 22.42.
What is the highest PE ratio for JNJ?
Over the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 291.08.
How does the current PE ratio for JNJ compare to its historical average?
JNJ's price to earnings ratio is currently 62% below its 10-year historical average.
How is JNJ's PE ratio calculated (Johnson & Johnson PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 9, 2025), Johnson & Johnson's share price is $154.22. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $9.06. Therefore, Johnson & Johnson's PE ratio for today is 17.02. PE RATIO(17.02) = STOCK PRICE($154.22) / TTM EPS($9.06)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.